Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000899243-21-036500)

Filing Details

Accession Number:: 0000899243-21-036500
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-09-17 21:48:07
Reporting Period:: 2021-09-15

Accepted Time:: 2021-09-17 21:48:07
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1656536	Decibel Therapeutics Inc.	DBTX	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1492749	Laurence Reid	C/O Decibel Therapeutics, Inc. 1325 Boylston Street, Suite 500 Boston MA 02215	President And Chief Executive	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2021-09-15	10,000	$7.64	25,849	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.587 to $7.65, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price.